BRPI0917417A2 - mnétodos de tratar deficiência cognitiva - Google Patents
mnétodos de tratar deficiência cognitivaInfo
- Publication number
- BRPI0917417A2 BRPI0917417A2 BRPI0917417A BRPI0917417A BRPI0917417A2 BR PI0917417 A2 BRPI0917417 A2 BR PI0917417A2 BR PI0917417 A BRPI0917417 A BR PI0917417A BR PI0917417 A BRPI0917417 A BR PI0917417A BR PI0917417 A2 BRPI0917417 A2 BR PI0917417A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- cognitive impairment
- treating cognitive
- treating
- impairment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8635108P | 2008-08-05 | 2008-08-05 | |
PCT/US2009/052742 WO2010017224A2 (en) | 2008-08-05 | 2009-08-04 | Methods of treating cognitive impairment |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0917417A2 true BRPI0917417A2 (pt) | 2015-12-01 |
Family
ID=41664174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0917417A BRPI0917417A2 (pt) | 2008-08-05 | 2009-08-04 | mnétodos de tratar deficiência cognitiva |
Country Status (10)
Country | Link |
---|---|
US (4) | US20110142795A1 (pt) |
EP (1) | EP2320934A4 (pt) |
JP (1) | JP2011530520A (pt) |
KR (1) | KR20110068993A (pt) |
CN (1) | CN102215860A (pt) |
BR (1) | BRPI0917417A2 (pt) |
CA (1) | CA2733126A1 (pt) |
MX (1) | MX2011001486A (pt) |
RU (1) | RU2011108560A (pt) |
WO (1) | WO2010017224A2 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9132168B2 (en) * | 2008-08-05 | 2015-09-15 | University Of South Florida | Methods of treating cognitive impairment |
KR20110068993A (ko) | 2008-08-05 | 2011-06-22 | 유니버시티 오브 사우스 플로리다 | 인지장애의 치료방법 |
EP2731970B1 (en) | 2011-07-15 | 2018-11-28 | MorphoSys AG | Antibodies that are cross-reactive for macrophage migration inhibitory factor (mif) and d-dopachrome tautomerase (d-dt) |
JP2014520873A (ja) | 2011-07-18 | 2014-08-25 | ザ ユニバーシティ オブ メルボルン | c−Fmsアンタゴニストの使用 |
KR20150140752A (ko) | 2013-04-12 | 2015-12-16 | 모르포시스 아게 | M-csf를 표적으로 하는 항체 |
WO2015020523A1 (en) | 2013-08-07 | 2015-02-12 | Stichting Vu-Vumc | Biomarkers for early diagnosis of alzheimer's disease |
WO2022174104A1 (en) * | 2021-02-12 | 2022-08-18 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for personalized treatment of neurodegenerative conditions or side effects thereof |
WO2023014881A1 (en) * | 2021-08-04 | 2023-02-09 | Washington University | Compositions and methods for enhancing brain perfusion |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5034322A (en) * | 1983-01-17 | 1991-07-23 | Monsanto Company | Chimeric genes suitable for expression in plant cells |
US4559157A (en) * | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
LU84979A1 (fr) * | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
US4820508A (en) * | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
US4992478A (en) * | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
US5167649A (en) * | 1988-08-22 | 1992-12-01 | Zook Gerald P | Drug delivery system for the removal of dermal lesions |
US4938949A (en) * | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
US5106739A (en) * | 1989-04-18 | 1992-04-21 | Calgene, Inc. | CaMv 355 enhanced mannopine synthase promoter and method for using same |
JPH04198134A (ja) * | 1990-11-28 | 1992-07-17 | Eisai Co Ltd | 老人性痴呆症の治療・予防剤 |
UA48104C2 (uk) * | 1991-10-04 | 2002-08-15 | Новартіс Аг | Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника |
CA2184498A1 (en) * | 1994-03-07 | 1995-09-14 | Stewart D. Lyman | Extracorporeal cell culture and transplantation kits |
JPH08113535A (ja) * | 1994-10-13 | 1996-05-07 | Sumitomo Pharmaceut Co Ltd | 神経細胞の変性または死滅抑制剤 |
JP2002535247A (ja) * | 1998-11-26 | 2002-10-22 | ペンタファルム アクチェンゲゼルシャフト | 輸送系複合体 |
US7345019B1 (en) * | 1999-04-13 | 2008-03-18 | The Kenneth S. Warren Institute, Inc. | Modulation of excitable tissue function by peripherally administered erythropoietin |
AU2001250912B2 (en) * | 2000-03-21 | 2007-01-04 | Curagen Corporation | VEGF-modulated genes and methods employing them |
US6960648B2 (en) * | 2000-10-13 | 2005-11-01 | Universite De Lausanne | Intracellular delivery of biological effectors |
US7033597B2 (en) * | 2000-10-13 | 2006-04-25 | Université de Lausanne | Intracellular delivery of biological effectors |
JP4055397B2 (ja) * | 2001-11-05 | 2008-03-05 | 信越化学工業株式会社 | 含フッ素有機ケイ素化合物 |
US20080318871A1 (en) * | 2001-12-21 | 2008-12-25 | Khan Nisar A | Treatment of neurological disorders |
KR20050019732A (ko) * | 2002-06-07 | 2005-03-03 | 코티컬 피티와이 리미티드 | 대식세포 유주 저지 인자의 생물학적 활성 또는사이토카인을 억제하는 나프탈렌 유도체 |
US20060275294A1 (en) * | 2002-08-22 | 2006-12-07 | Omoigui Osemwota S | Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer |
US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
AU2005306894B2 (en) * | 2004-11-05 | 2011-11-24 | Northwestern University | Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders |
US8329652B2 (en) * | 2005-05-10 | 2012-12-11 | Neoloch Aps | Neuritogenic peptides |
US8398972B2 (en) * | 2006-11-21 | 2013-03-19 | Kalobios Pharmaceuticals, Inc. | Methods of treating dementia using a GM-CSF antagonist |
WO2009029508A1 (en) | 2007-08-28 | 2009-03-05 | Johnnie B. Byrd, Sr. Alzheimer's Center And Research Institute, Inc. | Intracranial catheter and methods of use |
KR20110068993A (ko) * | 2008-08-05 | 2011-06-22 | 유니버시티 오브 사우스 플로리다 | 인지장애의 치료방법 |
US9132168B2 (en) * | 2008-08-05 | 2015-09-15 | University Of South Florida | Methods of treating cognitive impairment |
-
2009
- 2009-08-04 KR KR1020117005272A patent/KR20110068993A/ko not_active Application Discontinuation
- 2009-08-04 JP JP2011522171A patent/JP2011530520A/ja not_active Withdrawn
- 2009-08-04 RU RU2011108560/15A patent/RU2011108560A/ru unknown
- 2009-08-04 MX MX2011001486A patent/MX2011001486A/es not_active Application Discontinuation
- 2009-08-04 US US13/057,387 patent/US20110142795A1/en not_active Abandoned
- 2009-08-04 CA CA2733126A patent/CA2733126A1/en not_active Abandoned
- 2009-08-04 WO PCT/US2009/052742 patent/WO2010017224A2/en active Application Filing
- 2009-08-04 BR BRPI0917417A patent/BRPI0917417A2/pt not_active IP Right Cessation
- 2009-08-04 EP EP09805458A patent/EP2320934A4/en not_active Withdrawn
- 2009-08-04 CN CN2009801390789A patent/CN102215860A/zh active Pending
-
2013
- 2013-12-31 US US14/145,303 patent/US9682124B2/en active Active
-
2017
- 2017-03-15 US US15/459,947 patent/US20170189490A1/en not_active Abandoned
-
2020
- 2020-07-24 US US16/938,736 patent/US11896647B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
RU2011108560A (ru) | 2012-09-10 |
US20110142795A1 (en) | 2011-06-16 |
WO2010017224A2 (en) | 2010-02-11 |
US20210106654A1 (en) | 2021-04-15 |
WO2010017224A3 (en) | 2010-05-06 |
EP2320934A2 (en) | 2011-05-18 |
JP2011530520A (ja) | 2011-12-22 |
US20140255337A1 (en) | 2014-09-11 |
KR20110068993A (ko) | 2011-06-22 |
US9682124B2 (en) | 2017-06-20 |
US11896647B2 (en) | 2024-02-13 |
EP2320934A4 (en) | 2012-08-01 |
US20170189490A1 (en) | 2017-07-06 |
MX2011001486A (es) | 2011-05-02 |
CA2733126A1 (en) | 2010-02-11 |
CN102215860A (zh) | 2011-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0910854A2 (pt) | métodos de tratamento | |
BRPI0908276A2 (pt) | Métodos de tratar dor inflamatória | |
BRPI0924069A2 (pt) | métodos de diagnosticar e tratar disfagia | |
BRPI0921482A2 (pt) | tratamento de leucemia linfoblástica aguda | |
BRPI0910259A2 (pt) | métodos de tratamento de inflamação | |
DK2349132T3 (da) | Apparat til behandling af gerd | |
BRPI0912317A2 (pt) | método de autenticação | |
BRPI1010197A2 (pt) | métodos e compostos de pirazolopirimidina jak | |
BRPI1007477A2 (pt) | método, e, composição de tratamento de poço | |
BRPI0811265A2 (pt) | Tratamento de sinucleinopatias | |
BRPI0914294A2 (pt) | aparelho de tratamento de cápsulas | |
EP2504011A4 (en) | METHOD FOR TREATING EASY COGNITIVE IMPAIRMENT | |
BRPI0917417A2 (pt) | mnétodos de tratar deficiência cognitiva | |
BRPI1008744A2 (pt) | hidrotratamento de caboidratos | |
BRPI0919127A2 (pt) | métodos para tratamento de água | |
BRPI0916222A2 (pt) | método de tratamento e equipamento de tratamento de águas residuais | |
EP2350641A4 (en) | Methods of Treatment | |
BR112013012072A2 (pt) | derivados, composições de benzodiazepina e métodos para o tratamento de danos cognitivos | |
DK2554172T3 (da) | Fremgangsmåde til behandling af sygdomme | |
BRPI0916079A2 (pt) | tratamento de água marinha residual | |
BR112012003956A2 (pt) | método de tratar água residual | |
DE112010004214A5 (de) | Zugkraft-Abstandhalteranordnung, Verfahren zum Herstellen und Anwendung | |
DK2501381T3 (da) | Behandling af atrieflimmer | |
BRPI0811625A2 (pt) | Métodos de tratamento de distúrbios cognitivos através da inibição da gpr12 | |
BRPI0912043A2 (pt) | métodos de tratamento de doença associada à cinesina meiótica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |